ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 10th, 2024 • Point of Care Nano-Technology, Inc. • Biological products, (no disgnostic substances) • Nevada
This Asset Purchase Agreement is made and entered into May 20th, 2024 (the “Agreement”), by and between Point of Care Nano Technology, LLC. (“Point” or “POC”) duly incorporated or organized under the laws of Delaware (“Seller”), and Point of Care Nano Technology, Inc., a Nevada corporation publicly traded over the counter in the United States (the “U.S”) (“PCNT” or “Buyer”) (collectively, the “Parties” and, individually, a “Party”).
LICENSE AGREEMENT between POINT OF CARE NANO TECHNOLOGY, INC. and ZEUS DIAGNOSTICS, LLCLicense Agreement • June 10th, 2024 • Point of Care Nano-Technology, Inc. • Biological products, (no disgnostic substances) • Nevada
This License Agreement (the “Agreement”) is made and entered into May 20, 2024 (the “Effective Date”) by and between ZEUS Diagnostics, a Delaware (“ZEUS”) and Point of Care Nano Technology, a Nevada corporation trading on OTC markets with a business address in Davenport Florida (“PCNT”). ZEUS and PCNT are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
